当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 现金流量表

以岭药业

(002603)

  

流通市值:235.39亿  总市值:285.69亿
流通股本:13.77亿   总股本:16.71亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,459,554,280.378,491,648,565.266,123,725,514.934,096,951,718.03
  收到的税费返还5,331,940.6217,835,975.0615,814,249.810,983,581.72
  收到其他与经营活动有关的现金61,602,751.53285,518,572.42251,813,708.08194,952,597.89
  经营活动现金流入小计2,526,488,972.528,795,003,112.746,391,353,472.814,302,887,897.64
  购买商品、接受劳务支付的现金579,677,655.172,854,354,8552,122,582,744.321,399,269,183.84
  支付给职工以及为职工支付的现金463,319,323.471,798,057,987.681,272,351,615.07890,874,125.06
  支付的各项税费357,741,531.49916,811,896.61619,939,181.53436,449,671.81
  支付其他与经营活动有关的现金515,040,647.861,449,269,994.981,098,240,962.85744,254,840.97
  经营活动现金流出小计1,915,779,157.997,018,494,734.275,113,114,503.773,470,847,821.68
  经营活动产生的现金流量净额610,709,814.531,776,508,378.471,278,238,969.04832,040,075.96
二、投资活动产生的现金流量:
  收回投资收到的现金810,000,0001,493,500,000893,000,000793,000,000
  取得投资收益收到的现金4,679,962.94,078,192.991,473,331.581,159,120.01
  处置固定资产、无形资产和其他长期资产收回的现金净额-64,70041,637.1741,637.17
  投资活动现金流入小计814,679,962.91,497,642,892.99894,514,968.75794,200,757.18
  购建固定资产、无形资产和其他长期资产支付的现金54,183,825.3245,617,151.14172,041,905.9587,657,764.76
  投资支付的现金1,690,000,0002,254,000,0001,803,500,0001,353,500,000
  投资活动现金流出小计1,744,183,825.32,499,617,151.141,975,541,905.951,441,157,764.76
  投资活动产生的现金流量净额-929,503,862.4-1,001,974,258.15-1,081,026,937.2-646,957,007.58
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-501,211,612.8--
  支付其他与筹资活动有关的现金2,320,329.2512,421,534.157,307,247.285,423,118.14
  筹资活动现金流出小计2,320,329.25513,633,146.957,307,247.285,423,118.14
  筹资活动产生的现金流量净额-2,320,329.25-513,633,146.95-7,307,247.28-5,423,118.14
四、汇率变动对现金及现金等价物的影响274,475.71-812,591.14234,642.31143,861.51
五、现金及现金等价物净增加额-320,839,901.41260,088,382.23190,139,426.87179,803,811.75
  加:期初现金及现金等价物余额1,076,691,556.63816,603,174.4816,603,174.4816,603,174.4
  期末现金及现金等价物余额755,851,655.221,076,691,556.631,006,742,601.27996,406,986.15
补充资料:
  净利润-1,281,729,907.88-665,298,290.44
  资产减值准备-160,231,286.68-22,155,438.01
  固定资产和投资性房地产折旧-587,903,328.34-283,598,507.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-587,903,328.34-283,598,507.86
  无形资产摊销-28,827,746.3-14,285,571.65
  长期待摊费用摊销-3,085,129.48-1,261,525.8
  处置固定资产、无形资产和其他长期资产的损失-887,249.18--14,191.17
  固定资产报废损失-1,091,974.1--
  公允价值变动损失--3,922,789.94--
  财务费用-985,403.55-401,838.23
  投资损失--4,067,615.92--1,153,911.22
  递延所得税-142,341,049.54-56,494,805.31
  其中:递延所得税资产减少-147,485,539.92-58,355,936.27
    递延所得税负债增加--5,144,490.38--1,861,130.96
  存货的减少-170,930,463.66-259,403,092.16
  经营性应收项目的减少--169,202,249.83--437,072,295.63
  经营性应付项目的增加--416,869,787.4--36,252,562.16
  其他--18,179,693.16--
  现金的期末余额-1,076,691,556.63-996,406,986.15
  减:现金的期初余额-816,603,174.4-816,603,174.4
  现金及现金等价物的净增加额-260,088,382.23-179,803,811.75
公告日期2026-04-282026-04-282025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑